pharma news today glp-1 drugs transform obesity care, but challenges remain | DIGTINCTIVE posted on the topic BIG PHARMA NEWS: 7 GLP-1

To explain this finding, it may be noted that GltT, although required for L-glutamate transport, is highly homologous to the VacJ/Yrb ABC transport system, a proposed phospholipid transporter for maintaining lipid asymmetry in the Gram-negative outer membrane (Mla pathway) (Malinverni and Silhavy, 2009), also involved in outer membrane vesicle (OMV) formation (Roier et al., 2016)

Performing a Subcutaneous Injection: To perform a subcutaneous injection, follow these general steps: 1

Combination therapy with SGLT2 inhibitors + GLP-1 RAs may reduce cardiorenal risk and CV & all-cause mortality in T2D vs SGLT22 inhibitor and GLP-1 RA monotherapy

They both target the same receptor on the pituitary

& Valerio, C